Table 2 Antimicrobial susceptibility of MRSA from free-range cows.
Antimicrobial class | Antibiotics | Nasal isolates (n = 38) | Rectal isolates (n = 38) | Total isolates (n = 76) | ||||||
---|---|---|---|---|---|---|---|---|---|---|
R | I | S | R | I | S | R | I | S | ||
Penicillins | PEN | 38 (100) | 0 (0) | 0 (0) | 38 (100) | 0 (0) | 0 (0) | 76 (100) | 0 (0) | 0 (0) |
PTZ | 10 (26.3) | 17 (44.7) | 11 (28.9) | 17 (44.7) | 19 (50) | 2 (5.3) | 27 (35.5) | 36 (47.4) | 13 (17.1) | |
Streptogramins | QDA | 0 (0) | 0 (0) | 38 (100) | 0 (0) | 0 (0) | 38 (100) | 0 (0) | 0 (0) | 76 (100) |
Carbapenems | IMI | 3 (7.9) | 21 (55.3) | 14 (36.8) | 5 (13.2) | 23 (60.5) | 10 (26.3) | 8 (10.5) | 44 (57.9) | 24 (31.6) |
ETP | 21 (55.3) | 11 (28.9) | 6 (15.8) | 30 (78.9) | 8 (21.1) | 0 (0) | 51 (67.1) | 19 (25) | 6 (7.9) | |
MEM | 14 (36.8) | 19 (50) | 5 (13.2) | 21 (55.3) | 13 (34.2) | 4 (10.5) | 35 (46.1) | 32 (42.1) | 9 (11.8) | |
Lipoglycopeptides | ORI | 0 (0) | 0 (0) | 38 (100) | 0 (0) | 0 (0) | 38 (100) | 0 (0) | 0 (0) | 76 (100) |
TEI | 0 (0) | 0 (0) | 38 (100) | 0 (0) | 0 (0) | 38 (100) | 0 (0) | 0 (0) | 76 (100) | |
Aminoglycosides | KAN | 5 (13.2) | 3 (7.9) | 30 (78.9) | 11 (28.9) | 8 (21.1) | 19 (50) | 16 (21.1) | 11 (14.5) | 49 (64.5) |
GEN | 7 (18.4) | 6 (15.8) | 25 (65.8) | 13 (34.2) | 11 (28.9) | 14 (36.8) | 20 (26.3) | 17 (22.4) | 39 (51.3) | |
Tetracyclines | TET | 16 (42.1) | 12 (31.6) | 10 (26.3) | 20 (52.6) | 17 (44.7) | 1 (2.6) | 36 (47.4) | 29 (38.2) | 11 (14.5) |
Lincosamide | CLI | 19 (50) | 18 (47.4) | 1 (2.6) | 24 (63.2) | 13 (34.2) | 1 (2.6) | 43 (56.6) | 31 (40.8) | 2 (2.6) |
Macrolides | ERY | 10 (26.3) | 17 (44.7) | 11 (28.9) | 17 (44.7) | 18 (47.4) | 3 (7.9) | 27 (35.5) | 35 (46.1) | 14 (18.4) |
Lipopeptides | DAP | 0 (0) | 0 (0) | 38 (100) | 0 (0) | 0 (0) | 38 (100) | 0 (0) | 0 (0) | 76 (100) |
Fluoroquinolone | CIP | 10 (26.3) | 15 (39.5) | 13 (34.2) | 15 (39.5) | 19 (50) | 4 (10.5) | 25 (32.9) | 34 (44.7) | 17 (22.4) |
Oxazolidinones | LIZ | 0 (0) | 9 (23.7) | 29 (76.3) | 0 (0) | 5 (13.2) | 33 (86.8) | 0 (0) | 14 (18.4) | 62 (81.6) |
TED | 0 (0) | 0 (0) | 38 (100) | 0 (0) | 0 (0) | 38 (100) | 0 (0) | 0 (0) | 76 (100) | |
Cephalosporins | CRO | 38 (100) | 0 (0) | 0 (0) | 38 (100) | 0 (0) | 0 (0) | 76 (100) | 0 (0) | 0 (0) |
CTX | 38 (100) | 0 (0) | 0 (0) | 38 (100) | 0 (0) | 0 (0) | 76 (100) | 0 (0) | 0 (0) | |
Glycopeptides | VAN | 9 (23.7) | 4 (10.5) | 25 (65.8) | 17 (44.7) | 7 (18.4) | 14 (36.8) | 26 (34.2) | 11 (14.5) | 39 (51.3) |